HEREDITARY CANCER SCREENING
Video Coming Soon
Opportunity Type: Reference Laboratory
Opportunity Overview: DNA mutations can increase a patient’s susceptibility to certain cancers. Patients can be screened for these mutations to assess their level of risk. Our CGx partner one of the largest panels in the country and typically turnaround results in LESS than two weeks! These results can increase the identification of patients at high risk for certain diseases and potentially improve care by changing surveillance procedures or treatment of malignancies.
Specialties: All Specialties
This vendor pays a marketing services fee per the new EKRA legislation.
They use a sales portal that is directly tied to their clearinghouse so you have total transparency on utilization, specimen issues, and reimbursements.
STATES OF BUSINESS
All states but NY.
This product is a laboratory diagnostic tool so there is no revenue for the physicians.
2 weeks, one of the quickest in the industry.
Based on potential DNA mutations, a patient may have a susceptibility to certain types of cancer or disease. By allowing a provider to know ahead of time, the proper preventative measures can be taken.
The sales and clinic support from this vendor is on point! They have dedicated staff who help manage the clinics themselves which takes some of the load off of the representative.
Full training courses on the technology and selling techniques behind this product are offered through the Engage App.